046513107ATARA BIOTHERAPEUTICS INC
CUSIP 046513107 · common stock
No tracked investor reported shares of ATARA BIOTHERAPEUTICS INC (046513107) for Q4 2023. Seth Klarman sold out of its position this quarter.
Holders · Q4 2023
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding 046513107 · Q4 2023
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Seth Klarman | 0.28% | 9,773,616 | $14.5M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q4 2023 | 0 | 0 | 1 | $0 | — |
| Q3 2023 | 1 | 0 | 0 | $14.5M | $1.48 |
| Q2 2023 | 1 | 0 | 0 | $15.7M | $1.61 |
| Q1 2023 | 1 | 0 | 0 | $26.5M | $2.90 |
| Q4 2022 | 1 | 0 | 0 | $26.6M | $3.28 |
| Q3 2022 | 1 | 0 | 0 | $30.7M | $3.78 |
| Q2 2022 | 1 | 0 | 0 | $63.3M | $7.79 |
| Q1 2022 | 1 | 0 | 0 | $75.5M | $9.29 |
| Q4 2021 | 1 | 0 | 0 | $133.6M | $15.76 |
| Q3 2021 | 1 | 0 | 0 | $151.7M | $17.90 |
| Q2 2021 | 1 | 0 | 0 | $131.8M | $15.55 |
| Q1 2021 | 1 | 0 | 0 | $121.7M | $14.36 |
| Q4 2020 | 1 | 0 | 0 | $178.8M | $19.63 |
| Q3 2020 | 1 | 0 | 0 | $128.6M | $12.96 |
| Q2 2020 | 1 | 0 | 0 | $144.6M | $14.57 |
| Q1 2020 | 1 | 0 | 0 | $70.7M | $8.51 |
| Q4 2019 | 1 | 0 | 0 | $136.8M | $16.47 |
| Q3 2019 | 1 | 0 | 0 | $117.3M | $14.12 |
| Q2 2019 | 1 | 0 | 0 | $140.8M | $20.11 |
| Q1 2019 | 1 | 0 | 0 | $253.6M | $39.75 |
| Q4 2018 | 1 | 0 | 0 | $217.3M | $34.74 |
| Q3 2018 | 1 | 0 | 0 | $258.6M | $41.35 |
| Q2 2018 | 1 | 0 | 0 | $229.9M | $36.75 |
| Q1 2018 | 1 | 0 | 0 | $243.9M | $39.00 |
| Q4 2017 | 1 | 0 | 0 | $97M | $18.10 |
| Q3 2017 | 1 | 0 | 0 | $88.7M | $16.55 |
| Q2 2017 | 1 | 0 | 0 | $75M | $14.00 |
| Q1 2017 | 1 | 0 | 0 | $110.1M | $20.55 |
| Q4 2016 | 1 | 0 | 0 | $76.1M | $14.20 |
| Q3 2016 | 1 | 0 | 0 | $114.6M | $21.39 |
| Q2 2016 | 1 | 0 | 0 | $120.6M | $22.51 |
| Q1 2016 | 1 | 0 | 0 | $102M | $19.03 |
| Q4 2015 | 1 | 0 | 0 | $141.5M | $26.41 |
| Q3 2015 | 1 | 0 | 0 | $168.5M | $31.44 |
| Q2 2015 | 1 | 0 | 0 | $253.8M | $52.76 |
| Q1 2015 | 1 | 0 | 0 | $192.8M | $40.48 |
| Q4 2014 | 1 | 1 | 0 | $59.1M | $23.69 |